ID   CRUM1_HUMAN             Reviewed;        1406 AA.
AC   P82279; A2A308; B7Z5T2; B9EG71; Q5K3A6; Q5TC28; Q5VUT1; Q6N027; Q8WWY0;
AC   Q8WWY1;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2005, sequence version 2.
DT   28-JUN-2023, entry version 213.
DE   RecName: Full=Protein crumbs homolog 1 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=CRB1 {ECO:0000312|HGNC:HGNC:2343};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS RP12 VAL-161; TRP-250;
RP   MET-745; CYS-764; TYR-948; THR-1041 AND PRO-1071.
RC   TISSUE=Fetal brain, and Retina;
RX   PubMed=10508521; DOI=10.1038/13848;
RA   den Hollander A.I., ten Brink J.B., de Kok Y.J.M., van Soest S.,
RA   van den Born L.I., van Driel M.A., van de Pol D.J.R., Payne A.M.,
RA   Bhattacharya S.S., Kellner U., Hoyng C.B., Westerveld A., Brunner H.G.,
RA   Bleeker-Wagemakers E.M., Deutman A.F., Heckenlively J.R., Cremers F.P.M.,
RA   Bergen A.A.B.;
RT   "Mutations in a human homologue of Drosophila crumbs cause retinitis
RT   pigmentosa (RP12).";
RL   Nat. Genet. 23:217-221(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=11734541; DOI=10.1093/hmg/10.24.2767;
RA   den Hollander A.I., Johnson K., de Kok Y.J.M., Klebes A., Brunner H.G.,
RA   Knust E., Cremers F.P.M.;
RT   "CRB1 has a cytoplasmic domain that is functionally conserved between human
RT   and Drosophila.";
RL   Hum. Mol. Genet. 10:2767-2773(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), IDENTIFICATION IN COMPLEX WITH MPP4
RP   AND PALS1, TISSUE SPECIFICITY, AND GLYCOSYLATION.
RC   TISSUE=Retina;
RX   PubMed=15914641; DOI=10.1167/iovs.04-1417;
RA   Kantardzhieva A., Gosens I., Alexeeva S., Punte I.M., Versteeg I.,
RA   Krieger E., Neefjes-Mol C.A., den Hollander A.I., Letteboer S.J.F.,
RA   Klooster J., Cremers F.P.M., Roepman R., Wijnholds J.;
RT   "MPP5 recruits MPP4 to the CRB1 complex in photoreceptors.";
RL   Invest. Ophthalmol. Vis. Sci. 46:2192-2201(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INVOLVEMENT IN LCA8.
RX   PubMed=12567265; DOI=10.1076/opge.23.4.225.13879;
RA   Gerber S., Perrault I., Hanein S., Shalev S., Zlotogora J., Barbet F.,
RA   Ducroq D., Dufier J.-L., Munnich A., Rozet J., Kaplan J.;
RT   "A novel mutation disrupting the cytoplasmic domain of CRB1 in a large
RT   consanguineous family of Palestinian origin affected with Leber congenital
RT   amaurosis.";
RL   Ophthalmic Genet. 23:225-235(2002).
RN   [10]
RP   IDENTIFICATION IN COMPLEX WITH PALS1 AND EPB41L5, INTERACTION WITH PALS1
RP   AND EPB41L5, DEVELOPMENTAL STAGE, AND MUTAGENESIS OF 1377-GLY--TYR-1379 AND
RP   1403-GLU--ILE-1406.
RX   PubMed=17920587; DOI=10.1016/j.yexcr.2007.08.025;
RA   Gosens I., Sessa A., den Hollander A.I., Letteboer S.J.F., Belloni V.,
RA   Arends M.L., Le Bivic A., Cremers F.P.M., Broccoli V., Roepman R.;
RT   "FERM protein EPB41L5 is a novel member of the mammalian CRB-MPP5 polarity
RT   complex.";
RL   Exp. Cell Res. 313:3959-3970(2007).
RN   [11]
RP   VARIANTS LCA8 TYR-948 AND ARG-1100, VARIANTS RP12 CYS-433; CYS-764;
RP   HIS-837; TYR-948; ARG-1181 AND THR-1354, AND VARIANTS MET-289; MET-821;
RP   SER-894 AND HIS-1331.
RX   PubMed=11389483; DOI=10.1086/321263;
RA   den Hollander A.I., Heckenlively J.R., van den Born L.I., de Kok Y.J.M.,
RA   van der Velde-Visser S.D., Kellner U., Jurklies B., van Schooneveld M.J.,
RA   Blankenagel A., Rohrschneider K., Wissinger B., Cruysberg J.R.M.,
RA   Deutman A.F., Brunner H.G., Apfelstedt-Sylla E., Hoyng C.B.,
RA   Cremers F.P.M.;
RT   "Leber congenital amaurosis and retinitis pigmentosa with Coats-like
RT   exudative vasculopathy are associated with mutations in the crumbs
RT   homologue 1 (CRB1) gene.";
RL   Am. J. Hum. Genet. 69:198-203(2001).
RN   [12]
RP   ERRATUM OF PUBMED:11389483.
RA   den Hollander A.I., Heckenlively J.R., van den Born L.I., de Kok Y.J.M.,
RA   van der Velde-Visser S.D., Kellner U., Jurklies B., van Schooneveld M.J.,
RA   Blankenagel A., Rohrschneider K., Wissinger B., Cruysberg J.R.M.,
RA   Deutman A.F., Brunner H.G., Apfelstedt-Sylla E., Hoyng C.B.,
RA   Cremers F.P.M.;
RL   Am. J. Hum. Genet. 69:1160-1160(2001).
RN   [13]
RP   VARIANTS LCA8 VAL-144; TYR-383; GLY-480; ARG-480; TYR-681; CYS-764;
RP   TYR-948; ARG-1205 AND HIS-1317, AND VARIANTS MET-289; GLN-769 AND HIS-1331.
RX   PubMed=11231775; DOI=10.1001/archopht.119.3.415;
RA   Lotery A.J., Jacobson S.G., Fishman G.A., Weleber R.G., Fulton A.B.,
RA   Namperumalsamy P., Heon E., Levin A.V., Grover S., Rosenow J.R., Kopp K.K.,
RA   Sheffield V.C., Stone E.M.;
RT   "Mutations in the CRB1 gene cause Leber congenital amaurosis.";
RL   Arch. Ophthalmol. 119:415-420(2001).
RN   [14]
RP   VARIANT RP12 SER-1321.
RX   PubMed=11559858; DOI=10.1076/opge.22.3.163.2222;
RA   Lotery A.J., Malik A., Shami S.A., Sindhi M., Chohan B., Maqbool C.,
RA   Moore P.A., Denton M.J., Stone E.M.;
RT   "CRB1 mutations may result in retinitis pigmentosa without para-arteriolar
RT   RPE preservation.";
RL   Ophthalmic Genet. 22:163-169(2001).
RN   [15]
RP   VARIANTS RP12 ARG-846 AND PRO-1071, AND VARIANT LCA8 THR-989.
RX   PubMed=12573663; DOI=10.1016/s0014-4835(02)00304-4;
RA   Khaliq S., Abid A., Hameed A., Anwar K., Mohyuddin A., Azmat Z.,
RA   Shami S.A., Ismail M., Mehdi S.Q.;
RT   "Mutation screening of Pakistani families with congenital eye disorders.";
RL   Exp. Eye Res. 76:343-348(2003).
RN   [16]
RP   VARIANTS LCA8 SER-749 DEL; CYS-764; TYR-948 AND PHE-1218.
RX   PubMed=12700176; DOI=10.1093/hmg/ddg117;
RA   Jacobson S.G., Cideciyan A.V., Aleman T.S., Pianta M.J., Sumaroka A.,
RA   Schwartz S.B., Smilko E.E., Milam A.H., Sheffield V.C., Stone E.M.;
RT   "Crumbs homolog 1 (CRB1) mutations result in a thick human retina with
RT   abnormal lamination.";
RL   Hum. Mol. Genet. 12:1073-1078(2003).
RN   [17]
RP   VARIANTS RP12 SER-749 DEL; GLY-891; TYR-948; LEU-962 DEL AND THR-1100,
RP   VARIANT LCA8 THR-205, AND VARIANTS MET-289; GLU-679; HIS-769 AND HIS-1331.
RX   PubMed=12843338; DOI=10.1136/jmg.40.7.e89;
RA   Bernal S., Calaf M., Garcia-Hoyos M., Garcia-Sandoval B., Rosell J.,
RA   Adan A., Ayuso C., Baiget M.;
RT   "Study of the involvement of the RGR, CRPB1, and CRB1 genes in the
RT   pathogenesis of autosomal recessive retinitis pigmentosa.";
RL   J. Med. Genet. 40:E89-E89(2003).
RN   [18]
RP   VARIANTS LCA8 TYR-584; GLN-710; THR-741; MET-745; CYS-764; THR-852;
RP   TYR-948; ILE-1025; ARG-1103; ARG-1107; PRO-1107 AND SER-1321.
RX   PubMed=15024725; DOI=10.1002/humu.20010;
RA   Hanein S., Perrault I., Gerber S., Tanguy G., Barbet F., Ducroq D.,
RA   Calvas P., Dollfus H., Hamel C., Lopponen T., Munier F., Santos L.,
RA   Shalev S., Zafeiriou D., Dufier J.-L., Munnich A., Rozet J.-M., Kaplan J.;
RT   "Leber congenital amaurosis: comprehensive survey of the genetic
RT   heterogeneity, refinement of the clinical definition, and genotype-
RT   phenotype correlations as a strategy for molecular diagnosis.";
RL   Hum. Mutat. 23:306-317(2004).
RN   [19]
RP   VARIANTS RP12 PHE-195; GLU-578; TYR-587; MET-745; CYS-764; THR-836;
RP   SER-850; TYR-948; SER-959; ILE-986; THR-1100 AND HIS-1383, VARIANT LCA8
RP   THR-205, AND VARIANT GLN-905.
RX   PubMed=15459956; DOI=10.1002/humu.20093;
RA   den Hollander A.I., Davis J., van der Velde-Visser S.D., Zonneveld M.N.,
RA   Pierrottet C.O., Koenekoop R.K., Kellner U., van den Born L.I.,
RA   Heckenlively J.R., Hoyng C.B., Handford P.A., Roepman R., Cremers F.P.M.;
RT   "CRB1 mutation spectrum in inherited retinal dystrophies.";
RL   Hum. Mutat. 24:355-369(2004).
RN   [20]
RP   VARIANT PPCRA MET-162.
RX   PubMed=15623792; DOI=10.1167/iovs.04-0734;
RA   McKay G.J., Clarke S., Davis J.A., Simpson D.A., Silvestri G.;
RT   "Pigmented paravenous chorioretinal atrophy is associated with a mutation
RT   within the crumbs homolog 1 (CRB1) gene.";
RL   Invest. Ophthalmol. Vis. Sci. 46:322-328(2005).
RN   [21]
RP   VARIANTS LCA8 PRO-753; CYS-764 AND TYR-948.
RX   PubMed=15691574; DOI=10.1016/j.ophtha.2004.08.023;
RA   Galvin J.A., Fishman G.A., Stone E.M., Koenekoop R.K.;
RT   "Clinical phenotypes in carriers of Leber congenital amaurosis mutations.";
RL   Ophthalmology 112:349-356(2005).
RN   [22]
RP   VARIANTS LCA8 ARG-480; TYR-681; PRO-753; CYS-764 AND TYR-948, AND VARIANT
RP   SER-488.
RX   PubMed=16205573; DOI=10.1097/00006982-200510000-00016;
RA   Galvin J.A., Fishman G.A., Stone E.M., Koenekoop R.K.;
RT   "Evaluation of genotype-phenotype associations in Leber congenital
RT   amaurosis.";
RL   Retina 25:919-929(2005).
RN   [23]
RP   VARIANT LCA8 TYR-564.
RX   PubMed=17128490;
RA   Vallespin E., Riveiro-Alvarez R., Aguirre-Lamban J., Cantalapiedra D.,
RA   Tapias I., Garcia-Sandoval B., Trujillo-Tiebas M.J., Ayuso C.;
RT   "Gene symbol: CRB1. Disease: early onset retinitis pigmentosa.";
RL   Hum. Genet. 119:681-681(2006).
RN   [24]
RP   VARIANT LCA8 ARG-454.
RX   PubMed=16936081; DOI=10.1167/iovs.05-1637;
RA   Yzer S., Fishman G.A., Racine J., Al-Zuhaibi S., Chakor H., Dorfman A.,
RA   Szlyk J., Lachapelle P., van den Born L.I., Allikmets R., Lopez I.,
RA   Cremers F.P., Koenekoop R.K.;
RT   "CRB1 heterozygotes with regional retinal dysfunction: implications for
RT   genetic testing of Leber congenital amaurosis.";
RL   Invest. Ophthalmol. Vis. Sci. 47:3736-3744(2006).
RN   [25]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-745.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [26]
RP   VARIANT LCA8 PRO-535.
RX   PubMed=17438615;
RA   Vallespin E., Millan J.M., Riveiro-Alvarez R., Aguirre-Lamban J.,
RA   Cantalapiedra D., Gallego J., Trujillo-Tiebas M.J., Ayuso C.;
RT   "Gene symbol: CRB1.";
RL   Hum. Genet. 120:914-914(2007).
RN   [27]
RP   VARIANTS LCA8 TYR-438; MET-745; THR-852 AND ARG-1103, AND VARIANT MET-289.
RX   PubMed=17724218; DOI=10.1167/iovs.07-0068;
RA   Simonelli F., Ziviello C., Testa F., Rossi S., Fazzi E., Bianchi P.E.,
RA   Fossarello M., Signorini S., Bertone C., Galantuomo S., Brancati F.,
RA   Valente E.M., Ciccodicola A., Rinaldi E., Auricchio A., Banfi S.;
RT   "Clinical and molecular genetics of Leber's congenital amaurosis: a
RT   multicenter study of Italian patients.";
RL   Invest. Ophthalmol. Vis. Sci. 48:4284-4290(2007).
RN   [28]
RP   VARIANTS LCA8 TYR-939; TYR-948 AND PHE-1332.
RX   PubMed=18055821; DOI=10.1167/iovs.07-0610;
RA   den Hollander A.I., Lopez I., Yzer S., Zonneveld M.N., Janssen I.M.,
RA   Strom T.M., Hehir-Kwa J.Y., Veltman J.A., Arends M.L., Meitinger T.,
RA   Musarella M.A., van den Born L.I., Fishman G.A., Maumenee I.H.,
RA   Rohrschneider K., Cremers F.P., Koenekoop R.K.;
RT   "Identification of novel mutations in patients with Leber congenital
RT   amaurosis and juvenile RP by genome-wide homozygosity mapping with SNP
RT   microarrays.";
RL   Invest. Ophthalmol. Vis. Sci. 48:5690-5698(2007).
RN   [29]
RP   VARIANTS LCA8 ASP-333 AND THR-937, AND VARIANT HIS-769.
RX   PubMed=18682808;
RA   Seong M.W., Kim S.Y., Yu Y.S., Hwang J.M., Kim J.Y., Park S.S.;
RT   "Molecular characterization of Leber congenital amaurosis in Koreans.";
RL   Mol. Vis. 14:1429-1436(2008).
RN   [30]
RP   VARIANT RP12 ARG-1103.
RX   PubMed=19140180; DOI=10.1002/ajmg.a.32634;
RA   Benayoun L., Spiegel R., Auslender N., Abbasi A.H., Rizel L., Hujeirat Y.,
RA   Salama I., Garzozi H.J., Allon-Shalev S., Ben-Yosef T.;
RT   "Genetic heterogeneity in two consanguineous families segregating early
RT   onset retinal degeneration: the pitfalls of homozygosity mapping.";
RL   Am. J. Med. Genet. A 149:650-656(2009).
RN   [31]
RP   VARIANTS RP12 PHE-27 AND TRP-1165.
RX   PubMed=19956407;
RA   Aldahmesh M.A., Safieh L.A., Alkuraya H., Al-Rajhi A., Shamseldin H.,
RA   Hashem M., Alzahrani F., Khan A.O., Alqahtani F., Rahbeeni Z., Alowain M.,
RA   Khalak H., Al-Hazzaa S., Meyer B.F., Alkuraya F.S.;
RT   "Molecular characterization of retinitis pigmentosa in Saudi Arabia.";
RL   Mol. Vis. 15:2464-2469(2009).
RN   [32]
RP   VARIANT LCA8 CYS-1161.
RX   PubMed=20108431;
RA   Vallespin E., Avila-Fernandez A., Velez-Monsalve C., Almoguera B.,
RA   Martinez-Garcia M., Gomez-Dominguez B., Gonzalez-Roubaud C.,
RA   Cantalapiedra D., Trujillo-Tiebas M.J., Ayuso C.;
RT   "Novel human pathological mutations. Gene symbol: CRB1. Disease: Leber
RT   congenital amaurosis.";
RL   Hum. Genet. 127:119-119(2010).
RN   [33]
RP   INVOLVEMENT IN RETINAL DYSTROPHIES, VARIANTS EARLY-ONSET RETINAL DYSTROPHY
RP   TYR-310; CYS-764 AND TYR-948, AND VARIANT VAL-491.
RX   PubMed=20683928; DOI=10.1002/humu.21336;
RA   Coppieters F., Casteels I., Meire F., De Jaegere S., Hooghe S.,
RA   van Regemorter N., Van Esch H., Matuleviciene A., Nunes L., Meersschaut V.,
RA   Walraedt S., Standaert L., Coucke P., Hoeben H., Kroes H.Y.,
RA   Vande Walle J., de Ravel T., Leroy B.P., De Baere E.;
RT   "Genetic screening of LCA in Belgium: predominance of CEP290 and
RT   identification of potential modifier alleles in AHI1 of CEP290-related
RT   phenotypes.";
RL   Hum. Mutat. 31:E1709-E1766(2010).
RN   [34]
RP   VARIANTS RP12 TRP-45; VAL-710; MET-745; SER-850; ILE-901; TYR-948 AND
RP   HIS-1383, AND VARIANT HIS-769.
RX   PubMed=20591486; DOI=10.1016/j.ophtha.2010.02.029;
RA   Clark G.R., Crowe P., Muszynska D., O'Prey D., O'Neill J., Alexander S.,
RA   Willoughby C.E., McKay G.J., Silvestri G., Simpson D.A.;
RT   "Development of a diagnostic genetic test for simplex and autosomal
RT   recessive retinitis pigmentosa.";
RL   Ophthalmology 117:2169-2177(2010).
RN   [35]
RP   VARIANT RP12 LYS-1099.
RX   PubMed=21987686; DOI=10.1001/archophthalmol.2011.290;
RA   Azam M., Collin R.W., Malik A., Khan M.I., Shah S.T., Shah A.A.,
RA   Hussain A., Sadeque A., Arimadyo K., Ajmal M., Azam A., Qureshi N.,
RA   Bokhari H., Strom T.M., Cremers F.P., Qamar R., den Hollander A.I.;
RT   "Identification of novel mutations in Pakistani families with autosomal
RT   recessive retinitis pigmentosa.";
RL   Arch. Ophthalmol. 129:1377-1378(2011).
RN   [36]
RP   VARIANTS RP12 SER-157; TRP-250; LYS-312; CYS-675; VAL-710; MET-745;
RP   CYS-764; THR-836; ARG-846; TYR-948; SER-1012; ASN-1025 AND GLY-1174,
RP   VARIANTS LCA8 THR-205; SER-850; THR-1003; ARG-1103; PRO-1107; GLY-1174 AND
RP   LEU-1381, AND VARIANTS EARLY-ONSET RETINAL DYSTROPHY THR-741 AND ASP-1365.
RX   PubMed=20956273; DOI=10.1136/bjo.2010.186882;
RA   Henderson R.H., Mackay D.S., Li Z., Moradi P., Sergouniotis P.,
RA   Russell-Eggitt I., Thompson D.A., Robson A.G., Holder G.E., Webster A.R.,
RA   Moore A.T.;
RT   "Phenotypic variability in patients with retinal dystrophies due to
RT   mutations in CRB1.";
RL   Br. J. Ophthalmol. 95:811-817(2011).
RN   [37]
RP   VARIANT RP12 LEU-1305.
RX   PubMed=22128245;
RA   Siemiatkowska A.M., Arimadyo K., Moruz L.M., Astuti G.D.,
RA   de Castro-Miro M., Zonneveld M.N., Strom T.M., de Wijs I.J.,
RA   Hoefsloot L.H., Faradz S.M., Cremers F.P., den Hollander A.I., Collin R.W.;
RT   "Molecular genetic analysis of retinitis pigmentosa in Indonesia using
RT   genome-wide homozygosity mapping.";
RL   Mol. Vis. 17:3013-3024(2011).
RN   [38]
RP   VARIANTS LCA8 PRO-635 AND THR-741, AND VARIANTS LYS-222 AND MET-289.
RX   PubMed=21602930; DOI=10.1371/journal.pone.0019458;
RA   Li L., Xiao X., Li S., Jia X., Wang P., Guo X., Jiao X., Zhang Q.,
RA   Hejtmancik J.F.;
RT   "Detection of variants in 15 genes in 87 unrelated Chinese patients with
RT   Leber congenital amaurosis.";
RL   PLoS ONE 6:E19458-E19458(2011).
RN   [39]
RP   INVOLVEMENT IN RETINAL DYSTROPHIES, VARIANTS RP12 TYR-584; PHE-740;
RP   THR-741; THR-836; TYR-948 AND ARG-1103, AND VARIANTS EARLY-ONSET RETINAL
RP   DYSTROPHY ASN-789 DEL; CYS-1198 AND SER-1223.
RX   PubMed=22065545; DOI=10.1002/humu.21653;
RA   Bujakowska K., Audo I., Mohand-Said S., Lancelot M.E., Antonio A.,
RA   Germain A., Leveillard T., Letexier M., Saraiva J.P., Lonjou C.,
RA   Carpentier W., Sahel J.A., Bhattacharya S.S., Zeitz C.;
RT   "CRB1 mutations in inherited retinal dystrophies.";
RL   Hum. Mutat. 33:306-315(2012).
RN   [40]
RP   VARIANTS RP12 ASN-534 AND MET-745.
RX   PubMed=22334370; DOI=10.1002/humu.22045;
RA   Neveling K., Collin R.W., Gilissen C., van Huet R.A., Visser L.,
RA   Kwint M.P., Gijsen S.J., Zonneveld M.N., Wieskamp N., de Ligt J.,
RA   Siemiatkowska A.M., Hoefsloot L.H., Buckley M.F., Kellner U., Branham K.E.,
RA   den Hollander A.I., Hoischen A., Hoyng C., Klevering B.J.,
RA   van den Born L.I., Veltman J.A., Cremers F.P., Scheffer H.;
RT   "Next-generation genetic testing for retinitis pigmentosa.";
RL   Hum. Mutat. 33:963-972(2012).
RN   [41]
RP   INVOLVEMENT IN RETINAL DYSTROPHIES, VARIANTS LCA8 328-TRP--ILE-1406 DEL;
RP   ARG-948; TYR-948 AND 1226-GLY--ILE-1406 DEL, VARIANTS EARLY-ONSET RETINAL
RP   DYSTROPHY HIS-764 AND 1390-ARG--ILE-1406 DEL, VARIANTS RP12 THR-836 AND
RP   ARG-1107, AND VARIANTS PRO-479; PRO-921 AND ASN-1031.
RX   PubMed=28819299; DOI=10.1038/s41598-017-09035-1;
RA   Motta F.L., Salles M.V., Costa K.A., Filippelli-Silva R., Martin R.P.,
RA   Sallum J.M.F.;
RT   "The correlation between CRB1 variants and the clinical severity of
RT   Brazilian patients with different inherited retinal dystrophy phenotypes.";
RL   Sci. Rep. 7:8654-8654(2017).
RN   [42]
RP   VARIANT ASN-894 DEL.
RX   PubMed=30120214; DOI=10.1136/jmedgenet-2018-105364;
RA   de Bruijn S.E., Verbakel S.K., de Vrieze E., Kremer H., Cremers F.P.M.,
RA   Hoyng C.B., van den Born L.I., Roosing S.;
RT   "Homozygous variants in KIAA1549, encoding a ciliary protein, are
RT   associated with autosomal recessive retinitis pigmentosa.";
RL   J. Med. Genet. 55:705-712(2018).
CC   -!- FUNCTION: Plays a role in photoreceptor morphogenesis in the retina (By
CC       similarity). May maintain cell polarization and adhesion (By
CC       similarity). {ECO:0000250|UniProtKB:Q8VHS2}.
CC   -!- SUBUNIT: Component of a complex composed of PALS1, CRB1 and EPB41L5
CC       (PubMed:17920587). Within the complex, interacts (via intracellular
CC       domain) with PALS1 and EPB41L5 (via FERM domain) (PubMed:17920587).
CC       Forms a complex with MPP4 and PALS1 (PubMed:15914641). Interacts with
CC       MPDZ/MUPP1 and MPP4 (By similarity). {ECO:0000250|UniProtKB:Q8VHS2,
CC       ECO:0000269|PubMed:15914641, ECO:0000269|PubMed:17920587}.
CC   -!- INTERACTION:
CC       P82279; Q9HCM4: EPB41L5; NbExp=4; IntAct=EBI-1048648, EBI-1047162;
CC       P82279; Q96JB8: MPP4; NbExp=2; IntAct=EBI-1048648, EBI-2483346;
CC       P82279; Q8N3R9: PALS1; NbExp=5; IntAct=EBI-1048648, EBI-2513978;
CC       P82279; Q8NI35: PATJ; NbExp=2; IntAct=EBI-1048648, EBI-724390;
CC       P82279; Q58CU2: EPB41L5; Xeno; NbExp=2; IntAct=EBI-1048648, EBI-26451934;
CC       P82279; A0A3Q1LY00: PALS1; Xeno; NbExp=3; IntAct=EBI-1048648, EBI-26451960;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Apical cell membrane
CC       {ECO:0000250|UniProtKB:Q8VHS2}; Single-pass type I membrane protein
CC       {ECO:0000255}. Secreted {ECO:0000305}. Cell projection, cilium,
CC       photoreceptor outer segment {ECO:0000250|UniProtKB:Q8VHS2}.
CC       Photoreceptor inner segment {ECO:0000250|UniProtKB:Q8VHS2}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P82279-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P82279-2; Sequence=VSP_014728, VSP_014729;
CC       Name=3;
CC         IsoId=P82279-3; Sequence=VSP_014725;
CC       Name=4;
CC         IsoId=P82279-4; Sequence=VSP_014724, VSP_014726, VSP_014727;
CC       Name=5;
CC         IsoId=P82279-5; Sequence=VSP_045332;
CC   -!- TISSUE SPECIFICITY: Preferential expression in retina, also expressed
CC       in brain, testis, fetal brain and fetal eye (PubMed:15914641).
CC       Expressed at the outer limiting membrane and apical to adherens
CC       junctions in the retina (PubMed:15914641).
CC       {ECO:0000269|PubMed:15914641}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the retinal layer of the optic
CC       vesicle, and weakly expressed in the retinal pigment epithelium at 12.5
CC       dpc. {ECO:0000269|PubMed:17920587}.
CC   -!- PTM: Extensively glycosylated. {ECO:0000269|PubMed:15914641}.
CC   -!- DISEASE: Note=CRB1 mutations have been found in various retinal
CC       dystrophies, chronic and disabling disorders of visual function. They
CC       predominantly involve the posterior portion of the ocular fundus, due
CC       to degeneration in the sensory layer of the retina, retinal pigment
CC       epithelium, Bruch membrane, choroid, or a combination of these tissues.
CC       Onset of inherited retinal dystrophies is painless, bilateral and
CC       typically progressive. Most people experience gradual peripheral vision
CC       loss or tunnel vision, and difficulties with poor illumination and
CC       night vision. Central vision is usually unaffected, so the person may
CC       still be able to read. However, it can also deteriorate to cause total
CC       blindness. Examples of retinal dystrophies are retinitis pigmentosa,
CC       Leber congenital amaurosis, cone-rod dystrophy among others.
CC       {ECO:0000269|PubMed:20683928, ECO:0000269|PubMed:22065545,
CC       ECO:0000269|PubMed:28819299}.
CC   -!- DISEASE: Retinitis pigmentosa 12 (RP12) [MIM:600105]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies. Retinitis
CC       pigmentosa is characterized by retinal pigment deposits visible on
CC       fundus examination and primary loss of rod photoreceptor cells followed
CC       by secondary loss of cone photoreceptors. Patients typically have night
CC       vision blindness and loss of midperipheral visual field. As their
CC       condition progresses, they lose their far peripheral visual field and
CC       eventually central vision as well. RP12 is an autosomal recessive,
CC       severe form often manifesting in early childhood. Patients experiment
CC       progressive visual field loss with severe visual impairment before the
CC       age of twenty. Some patients have a preserved paraarteriolar retinal
CC       pigment epithelium (PPRPE) and hypermetropia.
CC       {ECO:0000269|PubMed:10508521, ECO:0000269|PubMed:11389483,
CC       ECO:0000269|PubMed:11559858, ECO:0000269|PubMed:12573663,
CC       ECO:0000269|PubMed:12843338, ECO:0000269|PubMed:15459956,
CC       ECO:0000269|PubMed:19140180, ECO:0000269|PubMed:19956407,
CC       ECO:0000269|PubMed:20591486, ECO:0000269|PubMed:20956273,
CC       ECO:0000269|PubMed:21987686, ECO:0000269|PubMed:22065545,
CC       ECO:0000269|PubMed:22128245, ECO:0000269|PubMed:22334370,
CC       ECO:0000269|PubMed:28819299}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Leber congenital amaurosis 8 (LCA8) [MIM:613835]: A severe
CC       dystrophy of the retina, typically becoming evident in the first years
CC       of life. Visual function is usually poor and often accompanied by
CC       nystagmus, sluggish or near-absent pupillary responses, photophobia,
CC       high hyperopia and keratoconus. {ECO:0000269|PubMed:11231775,
CC       ECO:0000269|PubMed:11389483, ECO:0000269|PubMed:12567265,
CC       ECO:0000269|PubMed:12573663, ECO:0000269|PubMed:12700176,
CC       ECO:0000269|PubMed:12843338, ECO:0000269|PubMed:15024725,
CC       ECO:0000269|PubMed:15459956, ECO:0000269|PubMed:15691574,
CC       ECO:0000269|PubMed:16205573, ECO:0000269|PubMed:16936081,
CC       ECO:0000269|PubMed:17128490, ECO:0000269|PubMed:17438615,
CC       ECO:0000269|PubMed:17724218, ECO:0000269|PubMed:18055821,
CC       ECO:0000269|PubMed:18682808, ECO:0000269|PubMed:20108431,
CC       ECO:0000269|PubMed:20956273, ECO:0000269|PubMed:21602930,
CC       ECO:0000269|PubMed:28819299}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Pigmented paravenous chorioretinal atrophy (PPCRA)
CC       [MIM:172870]: Unusual retinal degeneration characterized by
CC       accumulation of pigmentation along retinal veins. PPCRA is dominantly
CC       inherited, but exhibited variable expressivity. Males are more likely
CC       to exhibit a severe phenotype, whereas females may remain virtually
CC       asymptomatic even in later years. The PPCRA phenotype is associated
CC       with a mutation in CRB1 gene which is likely to affect the structure of
CC       the CRB1 protein. {ECO:0000269|PubMed:15623792}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Crumbs protein family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAE45845.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mutations of the CRB1 gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="https://www.retina-international.org/files/sci-news/crb1mut.htm";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF154671; AAF01361.1; -; mRNA.
DR   EMBL; AY043323; AAL10680.1; -; mRNA.
DR   EMBL; AY043324; AAL10681.1; -; mRNA.
DR   EMBL; AY043325; AAL10682.1; -; mRNA.
DR   EMBL; AJ748821; CAG38658.1; -; mRNA.
DR   EMBL; BX640729; CAE45845.1; ALT_SEQ; mRNA.
DR   EMBL; AK299368; BAH13018.1; -; mRNA.
DR   EMBL; AL136322; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL139136; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL513325; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356315; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW91277.1; -; Genomic_DNA.
DR   EMBL; BC136271; AAI36272.1; -; mRNA.
DR   CCDS; CCDS1390.1; -. [P82279-1]
DR   CCDS; CCDS53454.1; -. [P82279-3]
DR   CCDS; CCDS58052.1; -. [P82279-5]
DR   RefSeq; NP_001180569.1; NM_001193640.1. [P82279-3]
DR   RefSeq; NP_001244894.1; NM_001257965.1.
DR   RefSeq; NP_001244895.1; NM_001257966.1. [P82279-5]
DR   RefSeq; NP_957705.1; NM_201253.2. [P82279-1]
DR   PDB; 4UU5; X-ray; 1.23 A; B=1390-1406.
DR   PDBsum; 4UU5; -.
DR   AlphaFoldDB; P82279; -.
DR   SMR; P82279; -.
DR   BioGRID; 116990; 7.
DR   ComplexPortal; CPX-6167; CRUMBS1-PALS1-PATJ cell polarity complex.
DR   CORUM; P82279; -.
DR   IntAct; P82279; 9.
DR   MINT; P82279; -.
DR   STRING; 9606.ENSP00000356370; -.
DR   TCDB; 9.B.87.1.29; the selenoprotein p receptor (selp-receptor) family.
DR   GlyCosmos; P82279; 23 sites, No reported glycans.
DR   GlyGen; P82279; 23 sites.
DR   iPTMnet; P82279; -.
DR   PhosphoSitePlus; P82279; -.
DR   BioMuta; CRB1; -.
DR   DMDM; 71153499; -.
DR   MassIVE; P82279; -.
DR   MaxQB; P82279; -.
DR   PaxDb; P82279; -.
DR   PeptideAtlas; P82279; -.
DR   ProteomicsDB; 57705; -. [P82279-1]
DR   ProteomicsDB; 57706; -. [P82279-2]
DR   ProteomicsDB; 57707; -. [P82279-3]
DR   ProteomicsDB; 57708; -. [P82279-4]
DR   Antibodypedia; 34478; 84 antibodies from 24 providers.
DR   DNASU; 23418; -.
DR   Ensembl; ENST00000367399.6; ENSP00000356369.2; ENSG00000134376.17. [P82279-3]
DR   Ensembl; ENST00000367400.8; ENSP00000356370.3; ENSG00000134376.17. [P82279-1]
DR   Ensembl; ENST00000484075.5; ENSP00000433932.1; ENSG00000134376.17. [P82279-2]
DR   Ensembl; ENST00000538660.5; ENSP00000438091.1; ENSG00000134376.17. [P82279-5]
DR   Ensembl; ENST00000638467.1; ENSP00000491102.1; ENSG00000134376.17. [P82279-2]
DR   GeneID; 23418; -.
DR   KEGG; hsa:23418; -.
DR   MANE-Select; ENST00000367400.8; ENSP00000356370.3; NM_201253.3; NP_957705.1.
DR   UCSC; uc001gtz.4; human. [P82279-1]
DR   AGR; HGNC:2343; -.
DR   CTD; 23418; -.
DR   DisGeNET; 23418; -.
DR   GeneCards; CRB1; -.
DR   GeneReviews; CRB1; -.
DR   HGNC; HGNC:2343; CRB1.
DR   HPA; ENSG00000134376; Group enriched (brain, retina).
DR   MalaCards; CRB1; -.
DR   MIM; 172870; phenotype.
DR   MIM; 600105; phenotype.
DR   MIM; 604210; gene.
DR   MIM; 613835; phenotype.
DR   neXtProt; NX_P82279; -.
DR   OpenTargets; ENSG00000134376; -.
DR   Orphanet; 65; Leber congenital amaurosis.
DR   Orphanet; 35612; Nanophthalmos.
DR   Orphanet; 251295; Pigmented paravenous retinochoroidal atrophy.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA26863; -.
DR   VEuPathDB; HostDB:ENSG00000134376; -.
DR   eggNOG; KOG1217; Eukaryota.
DR   GeneTree; ENSGT00940000155152; -.
DR   HOGENOM; CLU_391592_0_0_1; -.
DR   InParanoid; P82279; -.
DR   OMA; NCTEFQG; -.
DR   OrthoDB; 2877476at2759; -.
DR   PhylomeDB; P82279; -.
DR   TreeFam; TF316224; -.
DR   PathwayCommons; P82279; -.
DR   SignaLink; P82279; -.
DR   BioGRID-ORCS; 23418; 6 hits in 1135 CRISPR screens.
DR   ChiTaRS; CRB1; human.
DR   GeneWiki; CRB1; -.
DR   GenomeRNAi; 23418; -.
DR   Pharos; P82279; Tbio.
DR   PRO; PR:P82279; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P82279; protein.
DR   Bgee; ENSG00000134376; Expressed in ganglionic eminence and 116 other tissues.
DR   ExpressionAtlas; P82279; baseline and differential.
DR   Genevisible; P82279; HS.
DR   GO; GO:0005912; C:adherens junction; IDA:UniProtKB.
DR   GO; GO:0043296; C:apical junction complex; NAS:ComplexPortal.
DR   GO; GO:0016324; C:apical plasma membrane; NAS:ComplexPortal.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0097386; C:glial cell projection; IEA:Ensembl.
DR   GO; GO:0005902; C:microvillus; IEA:Ensembl.
DR   GO; GO:0001917; C:photoreceptor inner segment; IEA:UniProtKB-SubCell.
DR   GO; GO:0001750; C:photoreceptor outer segment; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0035003; C:subapical complex; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0001974; P:blood vessel remodeling; IEA:Ensembl.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0071482; P:cellular response to light stimulus; IEA:Ensembl.
DR   GO; GO:0050908; P:detection of light stimulus involved in visual perception; IEA:Ensembl.
DR   GO; GO:0061159; P:establishment of bipolar cell polarity involved in cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0007163; P:establishment or maintenance of cell polarity; TAS:ProtInc.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IBA:GO_Central.
DR   GO; GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl.
DR   GO; GO:0010467; P:gene expression; IEA:Ensembl.
DR   GO; GO:0010001; P:glial cell differentiation; IEA:Ensembl.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IBA:GO_Central.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; IEA:Ensembl.
DR   GO; GO:0035845; P:photoreceptor cell outer segment organization; IEA:Ensembl.
DR   GO; GO:0007009; P:plasma membrane organization; IEA:Ensembl.
DR   GO; GO:0060060; P:post-embryonic retina morphogenesis in camera-type eye; IEA:Ensembl.
DR   GO; GO:0008104; P:protein localization; IEA:Ensembl.
DR   GO; GO:0010842; P:retina layer formation; IEA:Ensembl.
DR   CDD; cd00054; EGF_CA; 15.
DR   CDD; cd00110; LamG; 3.
DR   Gene3D; 2.60.120.200; -; 3.
DR   Gene3D; 2.10.25.10; Laminin; 17.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR001791; Laminin_G.
DR   PANTHER; PTHR24049; CRUMBS FAMILY MEMBER; 1.
DR   PANTHER; PTHR24049:SF1; PROTEIN CRUMBS HOMOLOG 1; 1.
DR   Pfam; PF00008; EGF; 13.
DR   Pfam; PF12661; hEGF; 3.
DR   Pfam; PF02210; Laminin_G_2; 3.
DR   PRINTS; PR00010; EGFBLOOD.
DR   PRINTS; PR01983; NOTCH.
DR   SMART; SM00181; EGF; 18.
DR   SMART; SM00179; EGF_CA; 16.
DR   SMART; SM00282; LamG; 3.
DR   SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 3.
DR   SUPFAM; SSF57196; EGF/Laminin; 8.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 2.
DR   PROSITE; PS00010; ASX_HYDROXYL; 10.
DR   PROSITE; PS00022; EGF_1; 15.
DR   PROSITE; PS01186; EGF_2; 11.
DR   PROSITE; PS50026; EGF_3; 19.
DR   PROSITE; PS01187; EGF_CA; 7.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell membrane;
KW   Cell projection; Disease variant; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Leber congenital amaurosis; Membrane; Reference proteome;
KW   Repeat; Retinitis pigmentosa; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..1406
FT                   /note="Protein crumbs homolog 1"
FT                   /id="PRO_0000007500"
FT   TOPO_DOM        26..1347
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1348..1368
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1369..1406
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          30..68
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          70..108
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          110..146
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          148..184
FT                   /note="EGF-like 4; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          186..222
FT                   /note="EGF-like 5; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          224..260
FT                   /note="EGF-like 6; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          262..299
FT                   /note="EGF-like 7; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          301..337
FT                   /note="EGF-like 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          339..395
FT                   /note="EGF-like 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          397..439
FT                   /note="EGF-like 10; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          441..481
FT                   /note="EGF-like 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          485..670
FT                   /note="Laminin G-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          672..708
FT                   /note="EGF-like 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          714..885
FT                   /note="Laminin G-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          887..923
FT                   /note="EGF-like 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          924..960
FT                   /note="EGF-like 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          950..1137
FT                   /note="Laminin G-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          1139..1175
FT                   /note="EGF-like 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1177..1212
FT                   /note="EGF-like 16; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1214..1250
FT                   /note="EGF-like 17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1255..1295
FT                   /note="EGF-like 18"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1297..1333
FT                   /note="EGF-like 19; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          1370..1406
FT                   /note="Interaction with EPB41L5"
FT                   /evidence="ECO:0000269|PubMed:17920587"
FT   CARBOHYD        30
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        41
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        42
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        215
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        287
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        313
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        322
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        418
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        427
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        453
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        550
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        561
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        657
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        757
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        871
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        880
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        968
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        975
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1000
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1190
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1243
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1265
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1273
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        34..45
FT                   /evidence="ECO:0000250"
FT   DISULFID        39..54
FT                   /evidence="ECO:0000250"
FT   DISULFID        56..67
FT                   /evidence="ECO:0000250"
FT   DISULFID        74..85
FT                   /evidence="ECO:0000250"
FT   DISULFID        79..96
FT                   /evidence="ECO:0000250"
FT   DISULFID        98..107
FT                   /evidence="ECO:0000250"
FT   DISULFID        114..125
FT                   /evidence="ECO:0000250"
FT   DISULFID        119..134
FT                   /evidence="ECO:0000250"
FT   DISULFID        136..145
FT                   /evidence="ECO:0000250"
FT   DISULFID        152..163
FT                   /evidence="ECO:0000250"
FT   DISULFID        157..172
FT                   /evidence="ECO:0000250"
FT   DISULFID        174..183
FT                   /evidence="ECO:0000250"
FT   DISULFID        190..201
FT                   /evidence="ECO:0000250"
FT   DISULFID        195..210
FT                   /evidence="ECO:0000250"
FT   DISULFID        212..221
FT                   /evidence="ECO:0000250"
FT   DISULFID        228..239
FT                   /evidence="ECO:0000250"
FT   DISULFID        233..248
FT                   /evidence="ECO:0000250"
FT   DISULFID        250..259
FT                   /evidence="ECO:0000250"
FT   DISULFID        266..277
FT                   /evidence="ECO:0000250"
FT   DISULFID        271..286
FT                   /evidence="ECO:0000250"
FT   DISULFID        288..298
FT                   /evidence="ECO:0000250"
FT   DISULFID        305..316
FT                   /evidence="ECO:0000250"
FT   DISULFID        310..325
FT                   /evidence="ECO:0000250"
FT   DISULFID        327..336
FT                   /evidence="ECO:0000250"
FT   DISULFID        343..354
FT                   /evidence="ECO:0000250"
FT   DISULFID        348..383
FT                   /evidence="ECO:0000250"
FT   DISULFID        385..394
FT                   /evidence="ECO:0000250"
FT   DISULFID        401..412
FT                   /evidence="ECO:0000250"
FT   DISULFID        406..421
FT                   /evidence="ECO:0000250"
FT   DISULFID        423..438
FT                   /evidence="ECO:0000250"
FT   DISULFID        445..456
FT                   /evidence="ECO:0000250"
FT   DISULFID        450..469
FT                   /evidence="ECO:0000250"
FT   DISULFID        471..480
FT                   /evidence="ECO:0000250"
FT   DISULFID        642..670
FT                   /evidence="ECO:0000250"
FT   DISULFID        676..687
FT                   /evidence="ECO:0000250"
FT   DISULFID        681..696
FT                   /evidence="ECO:0000250"
FT   DISULFID        698..707
FT                   /evidence="ECO:0000250"
FT   DISULFID        851..885
FT                   /evidence="ECO:0000250"
FT   DISULFID        891..902
FT                   /evidence="ECO:0000250"
FT   DISULFID        896..911
FT                   /evidence="ECO:0000250"
FT   DISULFID        913..922
FT                   /evidence="ECO:0000250"
FT   DISULFID        928..939
FT                   /evidence="ECO:0000250"
FT   DISULFID        933..948
FT                   /evidence="ECO:0000250"
FT   DISULFID        1096..1137
FT                   /evidence="ECO:0000250"
FT   DISULFID        1143..1154
FT                   /evidence="ECO:0000250"
FT   DISULFID        1148..1163
FT                   /evidence="ECO:0000250"
FT   DISULFID        1165..1174
FT                   /evidence="ECO:0000250"
FT   DISULFID        1181..1191
FT                   /evidence="ECO:0000250"
FT   DISULFID        1186..1200
FT                   /evidence="ECO:0000250"
FT   DISULFID        1202..1211
FT                   /evidence="ECO:0000250"
FT   DISULFID        1218..1229
FT                   /evidence="ECO:0000250"
FT   DISULFID        1223..1238
FT                   /evidence="ECO:0000250"
FT   DISULFID        1240..1249
FT                   /evidence="ECO:0000250"
FT   DISULFID        1259..1274
FT                   /evidence="ECO:0000250"
FT   DISULFID        1268..1283
FT                   /evidence="ECO:0000250"
FT   DISULFID        1285..1294
FT                   /evidence="ECO:0000250"
FT   DISULFID        1301..1312
FT                   /evidence="ECO:0000250"
FT   DISULFID        1306..1321
FT                   /evidence="ECO:0000250"
FT   DISULFID        1323..1332
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..351
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_014724"
FT   VAR_SEQ         218..329
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15914641"
FT                   /id="VSP_014725"
FT   VAR_SEQ         352..390
FT                   /note="GECVELSSEKQYGRITGLPSSFSYHEASGYVCICQPGFT -> MIRNSLCQP
FT                   SRCLDEYLFFNRKMFGARTHGFHILMAMLI (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_014726"
FT   VAR_SEQ         710..1245
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045332"
FT   VAR_SEQ         1294..1406
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_014727"
FT   VAR_SEQ         1336..1376
FT                   /note="LADDLISDIFTTIGSVTVALLLILLLAIVASVVTSNKRATQ -> VSSLSFY
FT                   VSLLFWQNLFQLLSYLILRMNDEPVVEWGEQEDY (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10508521,
FT                   ECO:0000303|PubMed:11734541"
FT                   /id="VSP_014728"
FT   VAR_SEQ         1377..1406
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10508521,
FT                   ECO:0000303|PubMed:11734541"
FT                   /id="VSP_014729"
FT   VARIANT         27
FT                   /note="C -> F (in RP12; dbSNP:rs1460946384)"
FT                   /evidence="ECO:0000269|PubMed:19956407"
FT                   /id="VAR_064180"
FT   VARIANT         45
FT                   /note="C -> W (in RP12; dbSNP:rs145141811)"
FT                   /evidence="ECO:0000269|PubMed:20591486"
FT                   /id="VAR_067125"
FT   VARIANT         144
FT                   /note="F -> V (in LCA8; dbSNP:rs62636262)"
FT                   /evidence="ECO:0000269|PubMed:11231775"
FT                   /id="VAR_022941"
FT   VARIANT         157
FT                   /note="C -> S (in RP12)"
FT                   /evidence="ECO:0000269|PubMed:20956273"
FT                   /id="VAR_067126"
FT   VARIANT         161
FT                   /note="A -> V (in RP12; dbSNP:rs62635651)"
FT                   /evidence="ECO:0000269|PubMed:10508521"
FT                   /id="VAR_011641"
FT   VARIANT         162
FT                   /note="V -> M (in PPCRA; dbSNP:rs137853138)"
FT                   /evidence="ECO:0000269|PubMed:15623792"
FT                   /id="VAR_022942"
FT   VARIANT         165..167
FT                   /note="Missing (in RP12)"
FT                   /id="VAR_067127"
FT   VARIANT         195
FT                   /note="C -> F (in RP12; dbSNP:rs764256655)"
FT                   /evidence="ECO:0000269|PubMed:15459956"
FT                   /id="VAR_022943"
FT   VARIANT         205
FT                   /note="I -> T (in LCA8; unknown pathological significance;
FT                   dbSNP:rs62645749)"
FT                   /evidence="ECO:0000269|PubMed:12843338,
FT                   ECO:0000269|PubMed:15459956, ECO:0000269|PubMed:20956273"
FT                   /id="VAR_022944"
FT   VARIANT         222
FT                   /note="E -> K (in dbSNP:rs114846212)"
FT                   /evidence="ECO:0000269|PubMed:21602930"
FT                   /id="VAR_067128"
FT   VARIANT         250
FT                   /note="C -> W (in RP12; dbSNP:rs62635652)"
FT                   /evidence="ECO:0000269|PubMed:10508521,
FT                   ECO:0000269|PubMed:20956273"
FT                   /id="VAR_011642"
FT   VARIANT         289
FT                   /note="T -> M (rare variant found in patients with retinal
FT                   dystrophy; does not segregate with the disease in a family;
FT                   unlikely to be pathogenic; dbSNP:rs62636263)"
FT                   /evidence="ECO:0000269|PubMed:11231775,
FT                   ECO:0000269|PubMed:11389483, ECO:0000269|PubMed:12843338,
FT                   ECO:0000269|PubMed:17724218, ECO:0000269|PubMed:21602930"
FT                   /id="VAR_022945"
FT   VARIANT         310
FT                   /note="C -> Y (probable disease-associated variant found in
FT                   patients with early-onset retinal dystrophy;
FT                   dbSNP:rs779835125)"
FT                   /evidence="ECO:0000269|PubMed:20683928"
FT                   /id="VAR_067129"
FT   VARIANT         312
FT                   /note="N -> K (in RP12)"
FT                   /evidence="ECO:0000269|PubMed:20956273"
FT                   /id="VAR_067130"
FT   VARIANT         328..1406
FT                   /note="Missing (in LCA8)"
FT                   /evidence="ECO:0000269|PubMed:28819299"
FT                   /id="VAR_079622"
FT   VARIANT         333
FT                   /note="G -> D (in LCA8; dbSNP:rs587783015)"
FT                   /evidence="ECO:0000269|PubMed:18682808"
FT                   /id="VAR_067131"
FT   VARIANT         383
FT                   /note="C -> Y (in LCA8; dbSNP:rs62645754)"
FT                   /evidence="ECO:0000269|PubMed:11231775"
FT                   /id="VAR_022946"
FT   VARIANT         433
FT                   /note="Y -> C (in RP12; dbSNP:rs62636288)"
FT                   /evidence="ECO:0000269|PubMed:11389483"
FT                   /id="VAR_022947"
FT   VARIANT         438
FT                   /note="C -> Y (in LCA8; dbSNP:rs1571522690)"
FT                   /evidence="ECO:0000269|PubMed:17724218"
FT                   /id="VAR_067132"
FT   VARIANT         454
FT                   /note="G -> R (in LCA8; dbSNP:rs954595597)"
FT                   /evidence="ECO:0000269|PubMed:16936081"
FT                   /id="VAR_067133"
FT   VARIANT         479
FT                   /note="L -> P (probable disease-associated variant found in
FT                   patients with rod-cone retinal dystrophy;
FT                   dbSNP:rs963201816)"
FT                   /evidence="ECO:0000269|PubMed:28819299"
FT                   /id="VAR_079623"
FT   VARIANT         480
FT                   /note="C -> G (in LCA8)"
FT                   /evidence="ECO:0000269|PubMed:11231775"
FT                   /id="VAR_022948"
FT   VARIANT         480
FT                   /note="C -> R (in LCA8; dbSNP:rs62636264)"
FT                   /evidence="ECO:0000269|PubMed:11231775,
FT                   ECO:0000269|PubMed:16205573"
FT                   /id="VAR_022949"
FT   VARIANT         488
FT                   /note="F -> S (in dbSNP:rs777377174)"
FT                   /evidence="ECO:0000269|PubMed:16205573"
FT                   /id="VAR_067134"
FT   VARIANT         491
FT                   /note="D -> V (found in a patient with early-onset retinal
FT                   dystrophy; unknown pathological significance;
FT                   dbSNP:rs1664299898)"
FT                   /evidence="ECO:0000269|PubMed:20683928"
FT                   /id="VAR_067135"
FT   VARIANT         534
FT                   /note="K -> N (in RP12)"
FT                   /evidence="ECO:0000269|PubMed:22334370"
FT                   /id="VAR_068363"
FT   VARIANT         535
FT                   /note="L -> P (in LCA8; dbSNP:rs113082791)"
FT                   /evidence="ECO:0000269|PubMed:17438615"
FT                   /id="VAR_067136"
FT   VARIANT         564
FT                   /note="D -> Y (in LCA8)"
FT                   /evidence="ECO:0000269|PubMed:17128490"
FT                   /id="VAR_067137"
FT   VARIANT         578
FT                   /note="V -> E (in RP12; dbSNP:rs1266363944)"
FT                   /evidence="ECO:0000269|PubMed:15459956"
FT                   /id="VAR_022950"
FT   VARIANT         584
FT                   /note="D -> Y (in LCA8; dbSNP:rs1664322968)"
FT                   /evidence="ECO:0000269|PubMed:15024725,
FT                   ECO:0000269|PubMed:22065545"
FT                   /id="VAR_022951"
FT   VARIANT         587
FT                   /note="C -> Y (in RP12; dbSNP:rs1471328495)"
FT                   /evidence="ECO:0000269|PubMed:15459956"
FT                   /id="VAR_022952"
FT   VARIANT         635
FT                   /note="S -> P (in LCA8; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:21602930"
FT                   /id="VAR_067138"
FT   VARIANT         675
FT                   /note="W -> C (in RP12)"
FT                   /evidence="ECO:0000269|PubMed:20956273"
FT                   /id="VAR_067139"
FT   VARIANT         679
FT                   /note="Q -> E (in dbSNP:rs62636286)"
FT                   /evidence="ECO:0000269|PubMed:12843338"
FT                   /id="VAR_022953"
FT   VARIANT         681
FT                   /note="C -> Y (in LCA8; dbSNP:rs62636266)"
FT                   /evidence="ECO:0000269|PubMed:11231775,
FT                   ECO:0000269|PubMed:16205573"
FT                   /id="VAR_022954"
FT   VARIANT         710
FT                   /note="E -> Q (in LCA8; dbSNP:rs62645755)"
FT                   /evidence="ECO:0000269|PubMed:15024725"
FT                   /id="VAR_022955"
FT   VARIANT         710
FT                   /note="E -> V (in RP12; dbSNP:rs145282040)"
FT                   /evidence="ECO:0000269|PubMed:20591486,
FT                   ECO:0000269|PubMed:20956273"
FT                   /id="VAR_067140"
FT   VARIANT         740
FT                   /note="S -> F (in RP12; dbSNP:rs1664649015)"
FT                   /evidence="ECO:0000269|PubMed:22065545"
FT                   /id="VAR_067141"
FT   VARIANT         741
FT                   /note="M -> T (in LCA8; also found in patients with
FT                   early-onset rod-cone retinal dystrophy; dbSNP:rs62636267)"
FT                   /evidence="ECO:0000269|PubMed:15024725,
FT                   ECO:0000269|PubMed:20956273, ECO:0000269|PubMed:21602930,
FT                   ECO:0000269|PubMed:22065545"
FT                   /id="VAR_022956"
FT   VARIANT         745
FT                   /note="T -> M (in RP12 and LCA8; dbSNP:rs28939720)"
FT                   /evidence="ECO:0000269|PubMed:10508521,
FT                   ECO:0000269|PubMed:15024725, ECO:0000269|PubMed:15459956,
FT                   ECO:0000269|PubMed:16959974, ECO:0000269|PubMed:17724218,
FT                   ECO:0000269|PubMed:20591486, ECO:0000269|PubMed:20956273,
FT                   ECO:0000269|PubMed:22334370"
FT                   /id="VAR_011643"
FT   VARIANT         749
FT                   /note="Missing (in RP12 and LCA8; dbSNP:rs62635653)"
FT                   /evidence="ECO:0000269|PubMed:12700176,
FT                   ECO:0000269|PubMed:12843338"
FT                   /id="VAR_022957"
FT   VARIANT         753
FT                   /note="L -> P (in LCA8; dbSNP:rs896160584)"
FT                   /evidence="ECO:0000269|PubMed:15691574,
FT                   ECO:0000269|PubMed:16205573"
FT                   /id="VAR_067142"
FT   VARIANT         764
FT                   /note="R -> C (in RP12 and LCA8; dbSNP:rs62635654)"
FT                   /evidence="ECO:0000269|PubMed:10508521,
FT                   ECO:0000269|PubMed:11231775, ECO:0000269|PubMed:11389483,
FT                   ECO:0000269|PubMed:12700176, ECO:0000269|PubMed:15024725,
FT                   ECO:0000269|PubMed:15459956, ECO:0000269|PubMed:15691574,
FT                   ECO:0000269|PubMed:16205573, ECO:0000269|PubMed:20683928,
FT                   ECO:0000269|PubMed:20956273"
FT                   /id="VAR_011644"
FT   VARIANT         764
FT                   /note="R -> H (found in a patient with early-onset retinal
FT                   dystrophy; unknown pathological significance;
FT                   dbSNP:rs375040930)"
FT                   /evidence="ECO:0000269|PubMed:28819299"
FT                   /id="VAR_079624"
FT   VARIANT         769
FT                   /note="R -> H (in dbSNP:rs62636287)"
FT                   /evidence="ECO:0000269|PubMed:12843338,
FT                   ECO:0000269|PubMed:18682808, ECO:0000269|PubMed:20591486"
FT                   /id="VAR_022958"
FT   VARIANT         769
FT                   /note="R -> Q"
FT                   /evidence="ECO:0000269|PubMed:11231775"
FT                   /id="VAR_022959"
FT   VARIANT         789
FT                   /note="Missing (in early-onset retinal dystrophy; probable
FT                   disease-associated variant; dbSNP:rs1433518605)"
FT                   /evidence="ECO:0000269|PubMed:22065545"
FT                   /id="VAR_067143"
FT   VARIANT         821
FT                   /note="T -> M (in dbSNP:rs142857810)"
FT                   /evidence="ECO:0000269|PubMed:11389483"
FT                   /id="VAR_067144"
FT   VARIANT         836
FT                   /note="P -> T (in RP12; dbSNP:rs116471343)"
FT                   /evidence="ECO:0000269|PubMed:15459956,
FT                   ECO:0000269|PubMed:20956273, ECO:0000269|PubMed:22065545,
FT                   ECO:0000269|PubMed:28819299"
FT                   /id="VAR_022960"
FT   VARIANT         837
FT                   /note="D -> H (in RP12; located on the same allele as
FT                   T-1354; dbSNP:rs62636289)"
FT                   /evidence="ECO:0000269|PubMed:11389483"
FT                   /id="VAR_022961"
FT   VARIANT         846
FT                   /note="G -> R (in RP12; dbSNP:rs539189291)"
FT                   /evidence="ECO:0000269|PubMed:12573663,
FT                   ECO:0000269|PubMed:20956273"
FT                   /id="VAR_022962"
FT   VARIANT         850
FT                   /note="G -> S (in RP12 and LCA8; dbSNP:rs776591659)"
FT                   /evidence="ECO:0000269|PubMed:15459956,
FT                   ECO:0000269|PubMed:20591486, ECO:0000269|PubMed:20956273"
FT                   /id="VAR_022963"
FT   VARIANT         852
FT                   /note="I -> T (in LCA8; dbSNP:rs62636271)"
FT                   /evidence="ECO:0000269|PubMed:15024725,
FT                   ECO:0000269|PubMed:17724218"
FT                   /id="VAR_022964"
FT   VARIANT         891
FT                   /note="C -> G (in RP12; without preservation of the
FT                   paraarteriolar retinal pigment epithelium;
FT                   dbSNP:rs62635658)"
FT                   /evidence="ECO:0000269|PubMed:12843338"
FT                   /id="VAR_022965"
FT   VARIANT         894
FT                   /note="N -> S (found in patients with retinitis pigmentosa;
FT                   unknown pathological significance; heterozygous;
FT                   dbSNP:rs62636290)"
FT                   /evidence="ECO:0000269|PubMed:11389483,
FT                   ECO:0000269|PubMed:30120214"
FT                   /id="VAR_022966"
FT   VARIANT         901
FT                   /note="V -> I (in RP12; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:20591486"
FT                   /id="VAR_067145"
FT   VARIANT         905
FT                   /note="R -> Q (in dbSNP:rs114052315)"
FT                   /evidence="ECO:0000269|PubMed:15459956"
FT                   /id="VAR_022967"
FT   VARIANT         921
FT                   /note="A -> P (probable disease-associated variant found in
FT                   patients with rod-cone retinal dystrophy)"
FT                   /evidence="ECO:0000269|PubMed:28819299"
FT                   /id="VAR_079625"
FT   VARIANT         937
FT                   /note="A -> T (in LCA8; unknown pathological significance;
FT                   dbSNP:rs114630940)"
FT                   /evidence="ECO:0000269|PubMed:18682808"
FT                   /id="VAR_067146"
FT   VARIANT         939
FT                   /note="C -> Y (in LCA8; dbSNP:rs1411345985)"
FT                   /evidence="ECO:0000269|PubMed:18055821"
FT                   /id="VAR_067147"
FT   VARIANT         948
FT                   /note="C -> R (in LCA8; dbSNP:rs62645747)"
FT                   /evidence="ECO:0000269|PubMed:28819299"
FT                   /id="VAR_079626"
FT   VARIANT         948
FT                   /note="C -> Y (in RP12 and LCA8; without preservation of
FT                   the paraarteriolar retinal pigment epithelium;
FT                   dbSNP:rs62645748)"
FT                   /evidence="ECO:0000269|PubMed:10508521,
FT                   ECO:0000269|PubMed:11231775, ECO:0000269|PubMed:11389483,
FT                   ECO:0000269|PubMed:12700176, ECO:0000269|PubMed:12843338,
FT                   ECO:0000269|PubMed:15024725, ECO:0000269|PubMed:15459956,
FT                   ECO:0000269|PubMed:15691574, ECO:0000269|PubMed:16205573,
FT                   ECO:0000269|PubMed:18055821, ECO:0000269|PubMed:20591486,
FT                   ECO:0000269|PubMed:20683928, ECO:0000269|PubMed:20956273,
FT                   ECO:0000269|PubMed:22065545, ECO:0000269|PubMed:28819299"
FT                   /id="VAR_011645"
FT   VARIANT         959
FT                   /note="G -> S (in RP12; unknown pathological significance;
FT                   dbSNP:rs557111131)"
FT                   /evidence="ECO:0000269|PubMed:15459956"
FT                   /id="VAR_022968"
FT   VARIANT         962
FT                   /note="Missing (in RP12; without preservation of the
FT                   paraarteriolar retinal pigment epithelium)"
FT                   /evidence="ECO:0000269|PubMed:12843338"
FT                   /id="VAR_022969"
FT   VARIANT         986
FT                   /note="N -> I (in RP12)"
FT                   /evidence="ECO:0000269|PubMed:15459956"
FT                   /id="VAR_022970"
FT   VARIANT         989
FT                   /note="I -> T (in LCA8)"
FT                   /evidence="ECO:0000269|PubMed:12573663"
FT                   /id="VAR_022971"
FT   VARIANT         1003
FT                   /note="I -> T (in LCA8; dbSNP:rs1409740542)"
FT                   /evidence="ECO:0000269|PubMed:20956273"
FT                   /id="VAR_067148"
FT   VARIANT         1012
FT                   /note="L -> S (in RP12)"
FT                   /evidence="ECO:0000269|PubMed:20956273"
FT                   /id="VAR_067149"
FT   VARIANT         1025
FT                   /note="S -> I (in LCA8; dbSNP:rs62636274)"
FT                   /evidence="ECO:0000269|PubMed:15024725"
FT                   /id="VAR_022972"
FT   VARIANT         1025
FT                   /note="S -> N (in RP12)"
FT                   /evidence="ECO:0000269|PubMed:20956273"
FT                   /id="VAR_067150"
FT   VARIANT         1031
FT                   /note="D -> N (probable disease-associated variant found in
FT                   patients with rod-cone retinal dystrophy)"
FT                   /evidence="ECO:0000269|PubMed:28819299"
FT                   /id="VAR_079627"
FT   VARIANT         1041
FT                   /note="M -> T (in RP12; dbSNP:rs62635656)"
FT                   /evidence="ECO:0000269|PubMed:10508521"
FT                   /id="VAR_011646"
FT   VARIANT         1071
FT                   /note="L -> P (in RP12; dbSNP:rs62635657)"
FT                   /evidence="ECO:0000269|PubMed:10508521,
FT                   ECO:0000269|PubMed:12573663"
FT                   /id="VAR_011647"
FT   VARIANT         1099
FT                   /note="T -> K (in RP12)"
FT                   /evidence="ECO:0000269|PubMed:21987686"
FT                   /id="VAR_067151"
FT   VARIANT         1100
FT                   /note="I -> R (in LCA8; dbSNP:rs62635659)"
FT                   /evidence="ECO:0000269|PubMed:11389483"
FT                   /id="VAR_011648"
FT   VARIANT         1100
FT                   /note="I -> T (in RP12; dbSNP:rs62635659)"
FT                   /evidence="ECO:0000269|PubMed:12843338,
FT                   ECO:0000269|PubMed:15459956"
FT                   /id="VAR_022973"
FT   VARIANT         1103
FT                   /note="G -> R (in LCA8 and RP12; dbSNP:rs62636275)"
FT                   /evidence="ECO:0000269|PubMed:15024725,
FT                   ECO:0000269|PubMed:17724218, ECO:0000269|PubMed:19140180,
FT                   ECO:0000269|PubMed:20956273, ECO:0000269|PubMed:22065545"
FT                   /id="VAR_022974"
FT   VARIANT         1107
FT                   /note="L -> P (in LCA8; dbSNP:rs62636276)"
FT                   /evidence="ECO:0000269|PubMed:15024725,
FT                   ECO:0000269|PubMed:20956273"
FT                   /id="VAR_022975"
FT   VARIANT         1107
FT                   /note="L -> R (in LCA8 and RP12; dbSNP:rs62636276)"
FT                   /evidence="ECO:0000269|PubMed:15024725,
FT                   ECO:0000269|PubMed:28819299"
FT                   /id="VAR_022976"
FT   VARIANT         1161
FT                   /note="Y -> C (in LCA8; dbSNP:rs1414707912)"
FT                   /evidence="ECO:0000269|PubMed:20108431"
FT                   /id="VAR_067152"
FT   VARIANT         1165
FT                   /note="C -> W (in RP12; dbSNP:rs1665099725)"
FT                   /evidence="ECO:0000269|PubMed:19956407"
FT                   /id="VAR_064181"
FT   VARIANT         1174
FT                   /note="C -> G (in LCA8 and RP12; dbSNP:rs917768074)"
FT                   /evidence="ECO:0000269|PubMed:20956273"
FT                   /id="VAR_067153"
FT   VARIANT         1181
FT                   /note="C -> R (in RP12; dbSNP:rs62636291)"
FT                   /evidence="ECO:0000269|PubMed:11389483"
FT                   /id="VAR_011649"
FT   VARIANT         1198
FT                   /note="Y -> C (probable disease-associated variant found in
FT                   patients with early-onset retinal dystrophy)"
FT                   /evidence="ECO:0000269|PubMed:22065545"
FT                   /id="VAR_067154"
FT   VARIANT         1205
FT                   /note="G -> R (in LCA8; dbSNP:rs574742644)"
FT                   /evidence="ECO:0000269|PubMed:11231775"
FT                   /id="VAR_022977"
FT   VARIANT         1218
FT                   /note="C -> F (in LCA8)"
FT                   /evidence="ECO:0000269|PubMed:12700176"
FT                   /id="VAR_022978"
FT   VARIANT         1223
FT                   /note="C -> S (probable disease-associated variant found in
FT                   patients with early-onset retinal dystrophy)"
FT                   /evidence="ECO:0000269|PubMed:22065545"
FT                   /id="VAR_067155"
FT   VARIANT         1226..1406
FT                   /note="Missing (in LCA8)"
FT                   /evidence="ECO:0000269|PubMed:28819299"
FT                   /id="VAR_079628"
FT   VARIANT         1305
FT                   /note="P -> L (in RP12; dbSNP:rs1391910861)"
FT                   /evidence="ECO:0000269|PubMed:22128245"
FT                   /id="VAR_067156"
FT   VARIANT         1317
FT                   /note="N -> H (in LCA8; dbSNP:rs62636281)"
FT                   /evidence="ECO:0000269|PubMed:11231775"
FT                   /id="VAR_022979"
FT   VARIANT         1321
FT                   /note="C -> S (in LCA8; also early onset RP without
FT                   preservation of the paraarteriolar retinal pigment
FT                   epithelium; dbSNP:rs62635649)"
FT                   /evidence="ECO:0000269|PubMed:11559858,
FT                   ECO:0000269|PubMed:15024725"
FT                   /id="VAR_022980"
FT   VARIANT         1331
FT                   /note="R -> H (in dbSNP:rs62636285)"
FT                   /evidence="ECO:0000269|PubMed:11231775,
FT                   ECO:0000269|PubMed:11389483, ECO:0000269|PubMed:12843338"
FT                   /id="VAR_022981"
FT   VARIANT         1332
FT                   /note="C -> F (in LCA8; dbSNP:rs377543137)"
FT                   /evidence="ECO:0000269|PubMed:18055821"
FT                   /id="VAR_067157"
FT   VARIANT         1354
FT                   /note="A -> T (in RP12; located on the same allele as
FT                   H-837; dbSNP:rs200469148)"
FT                   /evidence="ECO:0000269|PubMed:11389483"
FT                   /id="VAR_022982"
FT   VARIANT         1365
FT                   /note="A -> D (probable disease-associated variant found in
FT                   patients with early-onset retinal dystrophy)"
FT                   /evidence="ECO:0000269|PubMed:20956273"
FT                   /id="VAR_067158"
FT   VARIANT         1381
FT                   /note="P -> L (in LCA8)"
FT                   /evidence="ECO:0000269|PubMed:20956273"
FT                   /id="VAR_067159"
FT   VARIANT         1383
FT                   /note="R -> H (in RP12; dbSNP:rs200573274)"
FT                   /evidence="ECO:0000269|PubMed:15459956,
FT                   ECO:0000269|PubMed:20591486"
FT                   /id="VAR_022983"
FT   VARIANT         1390..1406
FT                   /note="Missing (found in a patient with early-onset retinal
FT                   dystrophy; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:28819299"
FT                   /id="VAR_079629"
FT   MUTAGEN         1377..1379
FT                   /note="Missing: Abolishes interaction with EPB41L5. No
FT                   effection on interaction wtih PALS1."
FT                   /evidence="ECO:0000269|PubMed:17920587"
FT   MUTAGEN         1403..1406
FT                   /note="Missing: Abolishes interaction with PALS1. Not
FT                   required for interaction with EPB41L5."
FT                   /evidence="ECO:0000269|PubMed:17920587"
FT   TURN            1394..1396
FT                   /evidence="ECO:0007829|PDB:4UU5"
FT   STRAND          1403..1406
FT                   /evidence="ECO:0007829|PDB:4UU5"
FT   VARIANT         P82279-2:1361
FT                   /note="R -> H (found in a patient with Leber congenital
FT                   amaurosis; unknown pathological significance)"
FT                   /evidence="ECO:0000305"
FT                   /id="VAR_082818"
SQ   SEQUENCE   1406 AA;  154183 MW;  F2D04D20FAA6E37D CRC64;
     MALKNINYLL IFYLSFSLLI YIKNSFCNKN NTRCLSNSCQ NNSTCKDFSK DNDCSCSDTA
     NNLDKDCDNM KDPCFSNPCQ GSATCVNTPG ERSFLCKCPP GYSGTICETT IGSCGKNSCQ
     HGGICHQDPI YPVCICPAGY AGRFCEIDHD ECASSPCQNG AVCQDGIDGY SCFCVPGYQG
     RHCDLEVDEC ASDPCKNEAT CLNEIGRYTC ICPHNYSGVN CELEIDECWS QPCLNGATCQ
     DALGAYFCDC APGFLGDHCE LNTDECASQP CLHGGLCVDG ENRYSCNCTG SGFTGTHCET
     LMPLCWSKPC HNNATCEDSV DNYTCHCWPG YTGAQCEIDL NECNSNPCQS NGECVELSSE
     KQYGRITGLP SSFSYHEASG YVCICQPGFT GIHCEEDVNE CSSNPCQNGG TCENLPGNYT
     CHCPFDNLSR TFYGGRDCSD ILLGCTHQQC LNNGTCIPHF QDGQHGFSCL CPSGYTGSLC
     EIATTLSFEG DGFLWVKSGS VTTKGSVCNI ALRFQTVQPM ALLLFRSNRD VFVKLELLSG
     YIHLSIQVNN QSKVLLFISH NTSDGEWHFV EVIFAEAVTL TLIDDSCKEK CIAKAPTPLE
     SDQSICAFQN SFLGGLPVGM TSNGVALLNF YNMPSTPSFV GCLQDIKIDW NHITLENISS
     GSSLNVKAGC VRKDWCESQP CQSRGRCINL WLSYQCDCHR PYEGPNCLRE YVAGRFGQDD
     STGYVIFTLD ESYGDTISLS MFVRTLQPSG LLLALENSTY QYIRVWLERG RLAMLTPNSP
     KLVVKFVLND GNVHLISLKI KPYKIELYQS SQNLGFISAS TWKIEKGDVI YIGGLPDKQE
     TELNGGFFKG CIQDVRLNNQ NLEFFPNPTN NASLNPVLVN VTQGCAGDNS CKSNPCHNGG
     VCHSRWDDFS CSCPALTSGK ACEEVQWCGF SPCPHGAQCQ PVLQGFECIA NAVFNGQSGQ
     ILFRSNGNIT RELTNITFGF RTRDANVIIL HAEKEPEFLN ISIQDSRLFF QLQSGNSFYM
     LSLTSLQSVN DGTWHEVTLS MTDPLSQTSR WQMEVDNETP FVTSTIATGS LNFLKDNTDI
     YVGDRAIDNI KGLQGCLSTI EIGGIYLSYF ENVHGFINKP QEEQFLKIST NSVVTGCLQL
     NVCNSNPCLH GGNCEDIYSS YHCSCPLGWS GKHCELNIDE CFSNPCIHGN CSDRVAAYHC
     TCEPGYTGVN CEVDIDNCQS HQCANGATCI SHTNGYSCLC FGNFTGKFCR QSRLPSTVCG
     NEKTNLTCYN GGNCTEFQTE LKCMCRPGFT GEWCEKDIDE CASDPCVNGG LCQDLLNKFQ
     CLCDVAFAGE RCEVDLADDL ISDIFTTIGS VTVALLLILL LAIVASVVTS NKRATQGTYS
     PSRQEKEGSR VEMWNLMPPP AMERLI
//
